吸入式抗SARS-CoV-2及其变体的肝素多糖纳米诱饵
Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants.
作者信息
Tu Bin, Wang Huiyuan, An Xinran, Qu Jingkun, Li Qianqian, Gao Yanrong, Shi Mingjie, Qiu Hong, Huang Yongzhuo
机构信息
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
University of Chinese Academy of Sciences, Beijing 100049, China.
出版信息
Acta Pharm Sin B. 2022 Jul;12(7):3187-3194. doi: 10.1016/j.apsb.2022.01.019. Epub 2022 Feb 11.
Abstract
The heparin polysaccharide nanoparticles block the interaction between heparan sulfate/S protein and inhibit the infection of both wild-type SARS-CoV-2 pseudovirus and the mutated strains through pulmonary delivery.Image 1.
摘要
肝素多糖纳米颗粒通过肺部给药阻断硫酸乙酰肝素/S蛋白之间的相互作用，并抑制野生型SARS-CoV-2假病毒和突变株的感染。图1。
Zotero 插件